Информация об этой странице недоступна. ·

What is CLL? Chronic lymphocytic leukemia (CLL) is cancer of B cells. Also called B lymphocytes, B cells are a type of white blood cell. White blood cells.

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · Guidelines · Evidence Blocks · Guidelines for Patients · Educational Events and Programs · International.

10 июн. 2022 г. · The treatment landscape of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has significantly evolved in recent years.

Patient Axtarishinar: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (2024). View all NCCN patient resources for Non-Hodgkin Lymphomas here.

Chronic Lymphocytic Leukemia. Guidelines for Patients. Chronic Lymphocytic Leukemia-English Version 2024. Chronic Lymphocytic Leukemia-Arabic Version 2021 ...

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is characterized by the accumulation of abnormal lymphocytes in the blood, bone marrow, ...

This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Chronic Lymphocytic Leukemia.

NCCN Guidelines® recommend acalabrutinib (CALQUENCE®) as a Category 1, preferred treatment option for CLL.

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) are posted with the latest update date and version number. NCCN Mobile Apps · Non-Small Cell Lung Cancer · Recently Updated Guidelines